Literature DB >> 25332557

Multicentric, Hyaline Vascular Variant of Castleman's Syndrome.

V Mukta1, Chandragiri Susmitha1, Rakhee Kar2, Debdatta Basu2, A K Das1.   

Abstract

Castleman's disease is a nonneoplastic adenopathy, also known as angiofollicular or giant lymphnode hyperplasia. Its multicentric form presents with wide spread lymphadenopathy and systemic symptoms. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes) is observed in 11-30 % of the patients with Castleman's disease (Dispenzieri et al., Blood 101:2496-2506, 2003). Tuberculosis and lymphoma are the common diagnosis in patients with clinical features of weight loss, lymphadenopathy, hepatosplenomegaly and lymphocyte predominant ascites. We had a similar presentation in a young male, who was a diabetic, with clinical features suggestive of probable tuberculous infiltration of abdomen and adrenals causing addisonian features, lymphocyte predominant ascites, hepatosplenomegaly and generalized lymphadenopathy. However, a pathological diagnosis of hyaline vascular variant of Castleman's disease was obtained on lymphnode biopsy, which propelled us into doing a skeletal survey and bonemarrow biopsy. A final diagnosis of multicentric Castleman's disease with reactive plasmacytosis was achieved. Patient had osteosclerotic lesion in the right femur with evidence of polyneuropathy, organomegaly, endocrinopathies and skin hyperpigmentation. He has improved on chemotherapy with melphan and dexamethasone. Hyaline vascular variant of Castleman's disease rarely presents with systemic symptoms. Follow up is essential, as they can manifest with complications like POEMS and lymphoma.

Entities:  

Keywords:  Castleman’s disease; Hyaline vascular variant; POEMS syndrome

Year:  2013        PMID: 25332557      PMCID: PMC4192236          DOI: 10.1007/s12288-013-0284-x

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  6 in total

1.  Antibodies to human herpesvirus 8 in POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes) syndrome with multicentric Castleman's disease.

Authors:  L Bélec; F J Authier; A S Mohamed; M Soubrier; R K Gherardi
Journal:  Clin Infect Dis       Date:  1999-03       Impact factor: 9.079

2.  POEMS Syndrome.

Authors:  Angela Dispenzieri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

3.  Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome.

Authors:  R K Gherardi; L Bélec; G Fromont; M Divine; D Malapert; P Gaulard; J D Degos
Journal:  Blood       Date:  1994-05-01       Impact factor: 22.113

4.  POEMS syndrome: definitions and long-term outcome.

Authors:  Angela Dispenzieri; Robert A Kyle; Martha Q Lacy; S Vincent Rajkumar; Terry M Therneau; Dirk R Larson; Philip R Greipp; Thomas E Witzig; Rita Basu; Guillermo A Suarez; Rafael Fonseca; John A Lust; Morie A Gertz
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

5.  Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome.

Authors:  O Watanabe; I Maruyama; K Arimura; I Kitajima; H Arimura; M Hanatani; K Matsuo; T Arisato; M Osame
Journal:  Muscle Nerve       Date:  1998-11       Impact factor: 3.217

Review 6.  Castleman disease: an update on classification and the spectrum of associated lesions.

Authors:  Danielle M P Cronin; Roger A Warnke
Journal:  Adv Anat Pathol       Date:  2009-07       Impact factor: 3.875

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.